About J-GLOBAL

日本語

Font size
  • A
  • A

Articleの詳細情報

ArticleJ-GLOBAL ID:200902131043334815整理番号:96A0336673

Combination Treatment of the Partial D2 Agonist Terguiride with the D1 Agonist SKF 82958 in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Parkinsonian Cynomolgus Monkeys.

1‐メチル‐4‐フェニル‐1,2,3,6‐テトラヒドロピリジン障害性Parkinson症のカニクイザルにおける部分D2作動薬であるテルグリドとD1作動薬SKF82958の併用適用

著者:AKAI T(Inst. Pharma Res., Dev. and Medical Sci., Osaka, JPN)、OZAWA M(Inst. Pharma Res., Dev. and Medical Sci., Osaka, JPN)、YAMAGUCHI M(Inst. Pharma Res., Dev. and Medical Sci., Osaka, JPN)・・・
資料名:J Pharmacol Exp Ther 巻:273 号:1 ページ:309-314
発行年:1995年04月
  • J-GLOBAL home
  • Bookmark J-GLOBAL

J-GLOBAL: Linking, Expanding and Sparking

About J-GLOBAL

Linking

J-GLOBAL links information that represents the key to research and development. For example, linking articles and patents with people (authors and inventors) enables the extraction of a sequence of information.
It’s useful for making new discoveries and uncovering new information.

Expanding

The system enables searches of similar kinds of content through linkage with external sites.
It helps you to obtain knowledge from dissimilar fields and discover concepts that cross the boundaries of specialisms.

Sparking

Through repeated linkage and expansioniteration, J-GLOBAL provides unexpected hints for problem-solving and the illumination of new ideas.